These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22533243)

  • 1. A case of allergic bronchopulmonary aspergillosis treated with omalizumab.
    Sastre I; Blanco J; Mata H; García F
    J Investig Allergol Clin Immunol; 2012; 22(2):145-7. PubMed ID: 22533243
    [No Abstract]   [Full Text] [Related]  

  • 2. Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab.
    Wolf BL; Johnson A
    J Allergy Clin Immunol Pract; 2014; 2(1):111-3. PubMed ID: 24565782
    [No Abstract]   [Full Text] [Related]  

  • 3. Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence.
    Tanou K; Zintzaras E; Kaditis AG
    Pediatr Pulmonol; 2014 May; 49(5):503-7. PubMed ID: 24167019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis.
    Wong R; Wong M; Robinson PD; Fitzgerald DA
    Paediatr Respir Rev; 2013 Mar; 14(1):22-4. PubMed ID: 23287795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic bronchopulmonary aspergillosis and omalizumab.
    Tillie-Leblond I; Germaud P; Leroyer C; Tétu L; Girard F; Devouassoux G; Grignet JP; Prudhomme A; Dusser D; Wallaert B
    Allergy; 2011 Sep; 66(9):1254-6. PubMed ID: 21517902
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.
    Zicari AM; Celani C; De Castro G; Valerio De Biase R; Duse M
    Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1839-41. PubMed ID: 25010610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Jat KR; Walia DK; Khairwa A
    Cochrane Database Syst Rev; 2013 Sep; (9):CD010288. PubMed ID: 24043500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Jat KR; Walia DK; Khairwa A
    Cochrane Database Syst Rev; 2015 Nov; (11):CD010288. PubMed ID: 26545165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Jat KR; Walia DK; Khairwa A
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010288. PubMed ID: 29551015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
    Lehmann S; Pfannenstiel C; Friedrichs F; Kröger K; Wagner N; Tenbrock K
    Ther Adv Respir Dis; 2014 Oct; 8(5):141-9. PubMed ID: 25150265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.
    Altman MC; Lenington J; Bronson S; Ayars AG
    J Allergy Clin Immunol Pract; 2017; 5(4):1137-1139. PubMed ID: 28279664
    [No Abstract]   [Full Text] [Related]  

  • 12. Omalizumab, an additional therapy for allergic bronchopulmonary aspergillosis.
    Evans MO; Morris MJ; Coop CA; Evans SE
    Ann Allergy Asthma Immunol; 2015 Sep; 115(3):250-1. PubMed ID: 26162570
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Benralizumab in a Patient Who Did Not Respond to Omalizumab.
    Bernal-Rubio L; de-la-Hoz Caballer B; Almonacid-Sánchez C; González-de-Olano D
    J Investig Allergol Clin Immunol; 2020; 30(5):378-379. PubMed ID: 32376515
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis].
    Delgado Pecellín I; Quintana Gallego E; Pedregal Solano C; Calero Acuña C
    Med Clin (Barc); 2015 Feb; 144(4):190-1. PubMed ID: 25015245
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-IgE therapy for allergic bronchopulmonary aspergillosis.
    Homma T; Kurokawa M; Matsukura S; Yamaguchi M; Adachi M
    J Microbiol Immunol Infect; 2016 Jun; 49(3):459-63. PubMed ID: 24291616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case series of allergic bronchopulmonary aspergillosis treated successfully and safely with long-term mepolizumab.
    Soeda S; To M; Kono Y; Yamawaki S; Tsuzuki R; Katsube O; Watanabe N; To Y
    Allergol Int; 2019 Jul; 68(3):377-379. PubMed ID: 30704844
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis.
    Voskamp AL; Gillman A; Symons K; Sandrini A; Rolland JM; O'Hehir RE; Douglass JA
    J Allergy Clin Immunol Pract; 2015; 3(2):192-9. PubMed ID: 25640470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.
    Perisson C; Destruys L; Grenet D; Bassinet L; Derelle J; Sermet-Gaudelus I; Thumerelle C; Prevotat A; Rosner V; Clement A; Corvol H
    Respir Med; 2017 Dec; 133():12-15. PubMed ID: 29173443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.
    Moss RB
    Ann N Y Acad Sci; 2012 Dec; 1272():49-57. PubMed ID: 23231714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis.
    Zirbes JM; Milla CE
    Pediatr Pulmonol; 2008 Jun; 43(6):607-10. PubMed ID: 18433040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.